We analyzed the relationship of genetic factors determining the expression of endogenous type-C RNA tumor viruses and other host-gene markers to tumorigenesis. A hybridization experiment was performed with mice of strains AKR/J and C57L, the first filial (F1) generation hybrids, the second filial (F2) generation hybrids, and the backcrosses to the two parental strains. The results demonstrated a highly significant and predictable association between the expression of complete infectious virus or the viral group-specific (gs) antigen in spleens of young mice and tumorigenesis later in life. Most of the tumors were thymic leukemia and reticulum sarcoma, but other mesenchymal, as well as epithelial, tumors were also observed. Tumors occurred preferentially in gs-antigen-or virus-positive mice of all crosses; in the C57L-backcross and F2 mice segregating for gs-antigen and virus expression, a few gs-antigen-negative mice developed reticulum cell sarcomas. At the time of their occurrence, the mice were all gs-antigen-positive, and most had virus as well.
A minor effect of the major histocompatibility locus, H-2, on leukemogenesis was found in the F2 mice. Several tumor types were also found that we have never observed in the two parental strains. Our data provide the most direct biological evidence in favor of the viral oncogene theory. Thus, from the presence or absence of expression in early life of splenic gs antigen or virus, we can predict whether or not a tumor is likely to develop later in life.
These findings suggest that the genome of endogenous type-C RNA viruses is the major determinant for tumorigenesis although they provide no clues about the factors responsible for the various histological types.
In studies on the inheritance of murine type-C RNA tumor (leukemia) virus (MuLV), we demonstrated specific host genetic regulation of expression (1) . Two autosomal dominant genes determine the group-specific (gs)-1 antigen and complete the virus. Strains lacking these genes must contain the viral glucose in covert form because gs antigen is frequently observed in old mice of such "switched-off" strains as C57BL/ 1OSn, SWR/J, and C57L/J (2); gs antigen may also be induced in negative mice with carcinogenic and other chemicals, and occasionally complete leukemogenic virus is recovered from "spontaneous" or carcinogen-and radiation-induced tumors (3) (4) (5) .
Although the oncogenicity of type-C RNA tumor viruses upon inoculation into appropriate hosts is unequivocal, the role of the expression of endogenous oncogenic viruses in "spontaneous" and chemical carcinogenesis is at most inferred from studies of gs-antigen or virus induction, and cellfree tumor transmission. To determine unequivocably a relationship, if any, of endogenous viral expression to tumorigenesis we performed a genetic hybridization experiment involving a strain with a high incidence of leukemia, AKR/J, and one with a low incidence, C57L/J, their reciprocal F1 hybrids, and the F2 and backcross generations of this cross. We found a highly significant association of gs-antigen or complete virus expression(s) and oncogenesis, i.e., from the presence or absence of complete infectious virus or gs antigen in spleens of young adult mice, we could predict whether or not individual mice will develop a tumor later in life. Furthermore, we found a weak association of the major histocompatibility locus (H-2) and of three other host genes with tumorigenesis.
MATERIALS AND METHODS
Mice and Breeding Methods. The parental strains, AKR/J and C57L/J, were obtained from the production colonies of The Jackson Laboratory. Mice of F1 and segregating generations were separated by sex at weaning, individually earmarked, and housed five per cage in stainless steel cages, 5 X 11 X 6 inches. Water and Old Guilford Laboratory chow were freely provided. Cages were changed at weekly intervals, when fresh bedding and water were provided. AKR/J and C57L/J mice were mated reciprocally to produce the two kinds of F1 mice. Parental and F1 mice were splenectomized at 4-6 weeks of age and then set aside for tumor development; the same procedure was followed for the F2 and backcross mice. virus; CF, complement fixation; MSV, murine sarcoma virus; RCS, reticulum cell sarcoma; BC, backcross gs, group specific. present in normal and tumor tissues. MSV-IX 322 is a tumorexudate pool from a rat infected with M-MSV that was used in a few sample retests. The sera gave identical reactions with the fourth antiserum used, a monospecific guinea-pig serum, prepared by hyperimmunization of the animal with highly purified gs antigen that had been separated on gels and isolectrofocused by Drs. R. V. Gilden We also used the XC-plaque assay for virus isolations and titrations (8, 9) . Unsonicated 10% (w/v) tissue extracts were inoculated onto SWR mouse-embryo tissue cultures in 50-mm petri dishes grown and maintained on minimal essential medium with 10% unheated fetal-calf serum, 2 mM glutamine, 250 units/ml of penicillin, and 250 ug/ml of streptomycin. The cultures were exposed to 25 Mg/ml of DEAEdextran for 1 hr at 370 and rinsed immediately before inoculation. 6 Days after virus inoculation the cultures were exposed to UV light for 25 sec from two germicidal bulbs at 60 ergs/ mm2 per sec, and 106 XC cells were added per dish. 4 Days later the dishes were fixed and stained with Giemsa stain. Virus titers were obtained by comparison of the percent plaquing efficiency of reference virus standards run simultaneously on SWR cells. Plaques were recognized by the absence of growth of XC cells, a Rous sarcoma virus-induced rat tumor line, in areas of syncytium formation.
Tumors and other tissues in gs-antigen-and virus-negative mice were also studied by electron microscopy for type-C virus particles. Tissues were fixed in 2% glutaraldehyde followed by dehydration with alcohol; they were then embedded in Araldite by standard procedures. The sections were evaluated in a Hitachi electron microscope, type HU-11C, at an accelerating voltage of 75 kV.
Genetic Analyses and Linkage Testing. Detailed genetic studies on the inheritance of the gs antigen and complete virus have been published (1) . The fact that spleens from all F1 and AKR-backcross (BC) mice were antigen-positive indicated that the gene(s) for the presence of the gs antigen is dominant to its allele for the absence of the antigen. However, we observed gs-antigen-and virus-negative segregants among F2 and C57L-BC mice. In C57L-BC progeny, the ratio of gspositive to gs-negative mice approximated a 3:1 ratio as if negative CF tests were due to simultaneous homozygosity genes. Results obtained in the F2 generation tended to support this interpretation, as a 15:1 positive to negative ratio was obtained. Data on virus isolation in C57L-BC and F2 mice suggested that most, if not all, gs-positive mice also had complete replicating virus. Thus, the segregation of gs antigen and virus in C57L-BC and F2 mice afforded us the opportunity of examining whether the appearance of tumors later in life could be predicted from the results of CF-and virustesting early in life.
We also typed the backcross-and F2-generation mice for several other genetic loci, to try mapping the genes controlling expression of antigen and complete viruses and to search for additional genetic determinants that may be relevant to tumorigenesis. The H-2 genotype was ascertained by erythrocyte agglutination (10) . The antiserum against H-2k was prepared by immunizing C3H-H-20 mice with C3H/DiSn spleen, thymus, and lymph node (11) . The antiserum against H-2bwas obtained from C3H/DiSn mice immunized with the same organs from A.SW and C57BL/lOSn mice. A few mice for Thy-i (Theta) and Ly-2 (Ly-B) were serotyped by in vitro absorption of cytotoxic antisera (11) . Preliminary experiments with non-H-2 antigens showed that frozen thymus could be teased upon thawing to yield cells with good specific absorptive capacity. These cells were counted and used at single, or occasionally several, concentrations to absorb separately antisera specific for Thy-1.1 (Theta-AKR), Thy-1.2 (Theta-C3H), Ly-2.1 (Ly-B.1), and Ly-2.2 (Ly-B.2).
Mice from the F2 and backcross to C57L/J were typed with respect to the electrophoretic variant of the #-chain of hemoglobin after hemolysate-alkylation (12 (Es-1 and Es-3), dipeptidase (Dip-i), and autosomal glucose-6-phosphate dehydrogenase (Gpd-i) (13) . Additional markers used were the three coat color genes, albinism (c), brown (b), and leaden (In).
Pathological Evaluation. When the mice set aside for tumor development were moribund they were killed. Tumors and other tissues were removed for diagnostic pathological and virological evaluation. We recorded deaths from all causes, and all diagnoses were verified histologically. The slides were read without knowledge of the phenotype with respect to gs antigen or virus.
RESULTS
Development and Types of Tumors. Strains AKR/J and C57L/J were selected for this experiment for two reasons: AKR/J mice are leukemia-prone, and their spleens are strictly CF-positive and contain infectious virus throughout life. C57L/J mice are gs-antigen-and virus-negative, and highly resistant to tumorigenesis even when 2-3 years old (14 (16, 17) .. Most of the gs-antigen-negative and virus-free BC-C57L mice died from conditions other than tumors, and their survival times (743 ± 32 days) were similar to those of mice dying with tumors (714 4 35 days). All of the tumors occurring in the mice that were originally gs-antigen and virus negative were RCS except for a single mammary adenocar- gs-AG+, positive for the group-specific (gs-1) antigen (gs-AG) or complete infectious virus; positive = 3+ or greater fixation of 1.8 units of complement; gs-AG-, negative for both gs-l and virus within the limits of our assays. Tumors of all types preferentially occurred in mice that were originally gs-antigen or virus positive; their appearance and incidence were significantly earlier and greater than those developing in mice that were originally gs-antigen and virus negative. Twice as many tumors occurred in mice that were gsantigen or virus positive before the first tumor developing in mice that were gs-antigen negative than the total cumulative incidence of tumor occurring in them. *, mice that were originally gs-antigen or virus positive (110 tumors); o, mice that were originally gs-antigen and virus negative (14 tumors (18, 19) indicated that splenectomy had no significant effect on the incidence, type, and latent period of spontaneous leukemia in mice of either AKR or C58 strain. Similarly, we found no tumor inhibition by splenectomy in two experiments involving the high-leukemia strain AKR/J and the RCS-prone strain, SJL/J. The rate of tumor development, the tumor incidence and type, as well as the survival times were no different between splenectomized and intact mice.
Association of Endogenous Viral Expression and Oncogenesis. Evidence for a role of endogenous oncogenic virus expression on subsequent tumor development (either "spontaneous" or chemically induced) has been mainly indirect. A relationship between virus expression and tumorigenesis must be shown to exist before development of tumors. Our results demonstrate that the probability for a young gs-antigen-or virus-positive mouse to develop a tumor is significantly greater (P < 0.001) than that for a gs-antigen-negative virusfree mouse. We found that the association of a positive antigen or virus status in early life with the development of a variety of tumors is highly predictable. Thus, the presence or absence of complete infectious virus or its gs antigen represents the best marker to predict whether or not an animal will develop a tumor.
The association of viral parameters controlled by the host genome with tumorigenesis is important for at least two reasons: risk groups (lines, strains, individuals) can be diagnosed before the appearance of tumors, and if both (regulatory and structural) genes for gs antigen and complete virus can be located, we may be closer to an answer regarding the possible chromosomal integration of the viral genome.
Previous findings indicated that some or all of the viral RNA also exists in the DNA of the host cell; full viral genomes can be activated by various forms of treatment and ". . . the development of (neutralizing) antibody to murine leukemia virus prior to the detection of overt lymphoma... suggests that unmasking of the latent leukemia virus is an indigenous actuating cause of the lymphoma" (4). Even in mice negative for gs antigen and virus expression that developed tumors later in life, tumorigenesis was accompanied by derepression of gs antigen, and complete virus in most instances. Thus, an etiological relationship can be inferred.
Although the association of gs antigen and virus expression with tumor development is highly significant, it is not absolute. This finding indicates that other host genes are reregulate virus expression, and that the presence or absence of gs antigen and virus is not an all-or-none phenomenon; indeed CF-positivity and negativity denote quantitative rather than qualitative differences within the limits of our assays.
The simultaneous development of different tumor types is exceedingly rare; only 6 of 277 tumor-bearing mice developed two types of tumor. Thus, the occurrence of one tumor usually excludes development of another.
Linkage Findings and Other Genes Affecting Tumorigenesis. We did not detect significant associations between any of the genetic markers and the genes regulating virus expression; thus, there is no close linkage between them and the viruscontrolling loci. However, we found a weak association of tumorigenesis with H-2 in F2 mice. This association is not likely fortuitous; it has also been observed in C3H X C57BL crosses (20) . In addition, Lilly has shown that the Rgv-1 locus causing resistance to leukemogenesis induced by Grosspassage A virus in neonatal mice is located in or just outside the K region of H-2 (21) . Similarly, the Ir-i gene, which determines immune responsiveness to certain antigens, is also located within the K region (22) . The Ir-i and Rgv-i genes may be identical and govern the immune capacity to viral or virus-induced cellular antigens. Thus, the H-2-associated influence on viral leukemogenesis may not be due to H-2 itself but to a gene within its recombination regions. Nevertheless, the H-2-associated effect is important because the HL-A system, which is the human homologue of H-2, appears to bear a relationship to the development of lymphoid and possibly other neoplasms.
The pattern of tumor development and tumor types other than lymphoreticular neoplasms in AKR-C57L crosses suggests effects of additional genetic factors or a multigenic control of tumor susceptibility. Indeed, the appearance of tumor types other than those characteristic of these two strains suggests that each strain may contribute genes relevant to various tumors. The possible linkage effects of Dip-i, Es-i, and In on tumorigenesis are being analyzed further with the aid of recombinant inbred strains (23) . Also, whether or not Fv-2, a gene located in linkage group II that determines Friend virus infection and replication, affects tumor development is currently being analyzed (24) . An effect of Fv-i, which influences the spleen focus formation in mice injected with Friend virus on either gs antigen, virus, or tumor development, could not be analyzed because it does not segregate in the AKR-C57L crosses (1, 25, 26 However, our frequent findings of perivascular cuffing, periand polyarteritis, peribronchial granulomatosis, and glomerulosclerosis parallel observations by others, which suggest that they may be due to an immune response to endogeneous tumor virus. For example, Hanna et al. (27) observed an increasing incidence with age of glomerulosclerosis in RFM mice that paralleled the appearance and amount of detectable renal MuLV antigens, IgG, and betaic globulin. Thus, they postulated that glomerulosclerosis may represent an "immune complex nephritis" similar to that in NZB mice. In addition, they found an inverse relationship between the incidence and severity of glomerulosclerosis and lymphoid neoplasia, suggesting that an immune response to endogenous
